Decreased ability to produce IL-17 could lead to reduced protection against bacterial, fungal, parasitic, and viral infections, especially at mucosal surfaces (Ishigame et al., 2009; Sen et al., 2013). This evidence concerns the gene IL17A and viral infectious disease.